# Short-term Metabolic Effects of Mirtazapine in Healthy Subjects

> **NCT00878540** · PHASE1 · COMPLETED · sponsor: **Max-Planck-Institute of Psychiatry** · enrollment: 12 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** mirtazapine

## Key facts

- **NCT ID:** NCT00878540
- **Lead sponsor:** Max-Planck-Institute of Psychiatry
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878540, "Short-term Metabolic Effects of Mirtazapine in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00878540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*